Nanovery, the Newcastle-based cutting-edge biotech company developing nanorobots that will be used to diagnose deadly diseases at an early stage, has completed a successful trial with NHS scientists. Nanovery’s system can detect biomarkers directly in…
Continue Reading
As part of the NHS Innovation Accelerator programme, Anya will be scaling up its breastfeeding support app across the NHS.The founder of the Gloucester-based company – formerly known as LatchAid – was one of…
Continue Reading
Abhi Sharma, Chief Product Officer for LoyalA new type of purpose-built technology is necessary to manage patient relationships.Customer relationship management (CRM) systems are commonplace in nearly every industry, though their use in healthcare is…
Continue Reading
Keith Algozzine, Founder and CEO of UCM Digital HealthProviding patients with a positive health outcome is always the priority for their healthcare provider. The journey to accomplishing this goal can often be an uphill…
Continue Reading
What You Should Know:– Cerner Enviza, an Oracle company, and FDA’s Sentinel Innovation Center are teaming up to develop AI tools to extract and assess clinical notes to better understand drug safety. – Teaming with…
Continue Reading
What You Should Know:– Clearday, an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp., a special…
Continue Reading
What You Should Know:Audio-only telehealth visits for both primary care and mental health services remained common at safety net clinics in California since the start of the COVID-19 pandemic, according to a new RAND Corporation…
Continue Reading
What You Should Know:– HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and…
Continue Reading
What You Should Know:– PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform.The platform supports phenotypic drug discovery, which unlike traditional target-based drug…
Continue Reading
CGI has been selected by Llesiant Delta Wellbeing – which has recently been awarded a TEC award – as its long-term strategic partner to improve health and social care outcomes in West Wales.The five-year…
Continue Reading
